Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charlton Stucken

Sports Medicine Boca Raton, FL Medical Doctor

NPI 1861667982 CMS profile 220498

1401 Nw 9Th Ave, Boca Raton, FL 33486

Open in the dashboard

General payments

$20,101

58 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charlton Stucken of Boca Raton, FL is reported in the CMS Open Payments database as having received $20,101 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,924 17
2024 General $419 9
2023 General $342 10
2022 General $236 3
2021 General $3,994 6
2020 General $6,253 7
2019 General $5,933 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charlton Stucken
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Charlton Stucken were reported at $2,924. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Charlton Stucken Sports Medicine median Middle half National median
2019 $5,933 $1,176 $199–$4,249 $163
2020 $6,253 $708 $96–$2,890 $114
2021 $3,994 $1,213 $152–$3,994 $132
2022 $236 $1,230 $159–$3,998 $149
2023 $342 $584 $146–$2,836 $160
2024 $419 $628 $163–$3,168 $164
2025 $2,924 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Advanced Orthopaedic Solutions, Inc. $11,900 5 payments
  2. Exactech, Inc. $3,001 6 payments
  3. Arthrex, Inc. $2,700 1 payment
  4. Zimmer Biomet Holdings, Inc. $714 7 payments
  5. Smith+Nephew, Inc. $474 10 payments
  6. Stryker Corporation $417 5 payments
  7. DePuy Synthes Sales Inc. $377 10 payments
  8. Medacta USA, Inc. $176 2 payments
  9. Carbofix Orthopedics Inc $96 1 payment
  10. Southern Edge Orthopaedics, Inc. $78 2 payments
  11. Other $168 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,900 5 payments
  2. Food and Beverage $3,266 48 payments
  3. Consulting Fee $2,700 1 payment
  4. Travel and Lodging $2,234 4 payments
Products named General payments · program years 2019–2025
  1. AOS PRODUCTS $8,100 3 payments
  2. AOS SYSTEMS $2,900 1 payment
  3. EQUINOXE Orthopaedic $1,873 3 payments
  4. EQUINOXE Orthopaedic $1,128 3 payments
  5. Trochanteric Nail $900 1 payment
  6. Comprehensive Shoulder System $224 2 payments
  7. AUGMENT INJECTABLE $223 2 payments
  8. MAKO $194 3 payments
  9. MONOVISC $183 6 payments
  10. TITAN Shoulder $147 1 payment
  11. Other $1,107 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

387

Median for Sports Medicine: 144

Drug cost

$5,365

Median for Sports Medicine: $1,027

Branded share of claims

56.3%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Er Diclofenac Sodium Brand 94 $2,458
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 113 $1,086
Ketorolac Tromethamine Generic 32 $667
Celecoxib Generic 25 $459
Methylprednisolone Generic 55 $375
Meloxicam Generic 19 $110
Tramadol Hcl Generic 22 $74
Ibuprofen Generic 16 $74
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $63

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$454,644

Of which drugs: $34,509

Medicare patients

1,056

Average age 75

Services billed

9,975

576 women, 480 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Ischemic heart disease 38%
Diabetes 23%
Osteoporosis 22%
Chronic kidney disease 21%
Depression 20%
Cancer 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 29 35 $18,594
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 14 18 $7,384
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 508 5,686 $4,209

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record